Sort by
Refine Your Search
-
. Develop research objectives and proposals for own or joint research, in the area of interest of the hosting laboratory (Prof. T. Carlomagno) Contribute to writing bids for research funding Acquire, analyse
-
in at any time. Background To create and contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research
-
effects on behavioural pain responses using preclinical OA models. The appointed person will primarily be supervised by Prof Simon W Jones (Department of Inflammation and Ageing, University of Birmingham
-
in at any time. Background The School of Mathematics welcomes applications for a research fellowship in statistics to work on the UKRI Future Leaders Fellowship project ‘Computational Statistics
-
development of future proposals for funding, into AI for renewable energy. You will consider ways in which the integration of machine learning algorithms might support the wider integration of, and uptake
-
Research Fellow (Fusion Shielding Materials) - School of Metallurgy and Materials - 105638 - Grade 7
of the research programme and/or specific research project Co-ordinate own work with others to avoid conflict or duplication of effort Knowledge of the protected characteristics of the Equality Act 2010, and how
-
administration and communication activities. The recruit will work with Dr Peter Hopcroft and Dr Thomas Pugh and Prof. Vincent Gauci. Role Summary Work within the DefMet interdisciplinary project team. Investigate
-
contribute to the creation of knowledge by undertaking a specified range of activities within an established research programme and/or specific research project. Our international group of highly motivated and
-
at the University of Birmingham is pleased to offer a Part-Time Research Fellow post funded through the NIHR DEMCOMM Fellowship Programme. This post supports a motivated qualitative researcher to contribute
-
(HPB). The medical oncology grouping sees close to 550 new cases of these cancers a year. There is a large active clinical trials programme that spans phase 1 to phase 3. These patients have a poor